Radiation for young patients with sarcoma that has spread
Part of Brain & nervous system, Cancer clinical trials.
This trial tests whether targeted radiation can help children and young adults with sarcoma that has spread to a few spots in the body. It's for those who are newly diagnosed (Stratum A) or whose sarcoma has come back or worsened (Stratum B).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are under 39 years old.
- You have a type of sarcoma (a cancer of the bones or soft tissues) that has been confirmed by a biopsy or genetic test.
- Your cancer has spread to at least one spot away from the main tumor, and that spot can be seen on a CT scan.
- You are healthy enough to get around and take care of yourself (performance score 70% or higher).
- You do not have cancer in the brain or spinal cord, or fluid buildup in the belly or chest from the cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of targeted radiation and special immune cells (CAR T cells) for children and young adults whose bone or soft tissue sarcoma has come back or not responded to standard treatments. The CAR T cells are made from your own blood cells and are designed to attack a protein called B7-H3 found on the sarcoma cells.
This Phase 2 trial tests a highly focused radiation treatment to shrink sarcoma that has spread to a limited number of spots in the body. It may help control disease while limiting radiation to healthier tissue.
This trial tests a combination of a PARP inhibitor drug, targeted radiation (SBRT), and immunotherapy for people with advanced sarcoma that has spread. It aims to see if this triple therapy can shrink tumors or slow the disease.
This trial tests a new type of radiation called spatially fractionated radiation therapy (SFRT) given before surgery for large soft tissue sarcomas in the arm, leg, or trunk. The goal is to see if it helps shrink the tumor and improve treatment outcomes.
This Phase 1/2 trial tests whether combining radiation with two targeted/immune medicines can shrink or control high-risk soft tissue sarcoma and improve outcomes. It may help patients whose tumors are large, hard to fully remove, or have come back after prior treatment.
This trial tests a newer way of giving radiation (spatially fractionated) compared to standard radiation for people with large soft tissue sarcomas. It aims to see if the new method works better.
Hear when a new Metastatic Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.